Welcome to the inaugural edition of Cedars-Sinai Medical Center's "Top Tips." This semi-monthly service is designed especially for health and medical reporters and is offered free of charge by the Cedars-Sinai Medical Center Public Relations Department. To receive "Top Tips" twice each month via e-mail, please send your name, organization, phone and fax numbers, plus e-mail address, to firstname.lastname@example.org. If you are already receiving this service and do not wish to, you may cancel by sending to the same e-mail address with the word "unsubscribe" entered in the subject field. To pursue any of these story ideas, call 1-800-396-1002. Thank you.
DIABETES DRUG AND ACCUTANE BLOCK BREAST CANCER CELL GROWTH
Breast cancer cells exposed to a diabetes drug (Troglitazone) and the Vitamin A compound Accutane stopped multiplying and died on cue in laboratory and animal studies conducted at Cedars-Sinai Medical Center. The drug combination appears to have no adverse effect on healthy cells, either in laboratory studies or in immunodeficient mice injected with human breast cells that form tumors.
Interview: H. Phillip Koeffler, M.D., Director of Hematology/Oncology, Cedars-Sinai
NEW BRAIN TUMOR SUPPORT GROUP OFFERS PATIENTS AND FAMILIES MONTHLY UPDATES
ON NEW TREATMENT OPTIONS PLUS PSYCHOLOGICAL SUPPORT
A new Brain Tumor Support Group at Cedars-Sinai Medical Center's Neurosurgical Institute provides patients and their families with psychological support as well as monthly updates on the latest in treatment options, including radiation, chemotherapy and future strategies using gene therapy and immunology. The series of programs combines medical updates with psychological support groups.
Interview: World-renowned brain surgeon Keith L. Black, M.D., and brain tumor patients
CLINICAL TRIALS AT CEDARS-SINAI OFFER NEW OPTION FOR ANGINA PAIN SUFFERERS
Cardiac patients who are t
Contact: Sandra Van or Roberta Nichols
Cedars-Sinai Medical Center